Personal Resume M.D., Associate Chief Physician, Deputy Director of the Department of Infectious Diseases and Hepatology, Peking University International Hospital. Graduated from the Department of Clinical Medicine, Second Military Medical University of the People's Liberation Army, and subsequently studied in the Infectious Diseases specialty at the PLA Medical College, obtaining both a master's and doctoral degree. After graduating from university, worked at PLA 302 Hospital, successively engaging in a series of clinical work on hepatitis, liver cirrhosis, liver failure, and liver cancer. In 2006, collaborated with the U.S. company ELAD and participated in the clinical validation of the earliest bioartificial liver to enter clinical use in China. Subsequently, took the lead in carrying out clinical treatment with offline bioartificial liver in China. Beginning in 2013, focused on the research and development of domestically produced offline bioartificial liver treatment instruments, completed the development of an offline bioartificial liver treatment device, and obtained 4 national invention patents. In 2014, transferred to the Department of Medical Oncology at 302 Hospital, began engaging in local ablation treatment for liver cancer, and participated in the clinical validation of the domestically developed AH-1 cryoablation treatment instrument as well as the first NanoKnife ablation procedure at 302 Hospital. At the same time, possesses rich clinical experience in areas such as tumor biological immunotherapy, molecular targeted therapy, and individualized precision treatment. In 2017, in response to the national call for disarmament, applied to transfer to civilian work. Since July 2017, has worked in the Department of Infectious Diseases and Hepatology at Peking University International Hospital, and in September 2017 was officially appointed Deputy Director of the Department of Infectious Diseases and Hepatology at Peking University International Hospital. Honors and Awards In terms of scientific research, presided over one formerly National 863 military classified project and one military equipment research and development program. Successively participated in the "Eleventh Five-Year," "Twelfth Five-Year," and "Thirteenth Five-Year" national key scientific research projects "Clinical Research on Nucleos(t)ide Analogues in the Treatment of Liver Failure." Participated in research for multiple National Natural Science Foundation projects, key military scientific research projects, and Capital Development Fund projects. Published more than 100 papers in Chinese, including 19 original research articles as first author. Published 13 SCI papers, including 5 as first author. Participated in the compilation of 10 textbooks and monographs. Received one Second Prize and two Third Prizes for Military Clinical Science and Technology Progress.